Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
23.39
-0.52 (-2.20%)
Sep 17, 2026, 3:38 PM EDT - Market open
Maze Therapeutics Revenue
Maze Therapeutics had revenue of $20.00M in the twelve months ending June 30, 2026, up 700.00% year-over-year.
Revenue (ttm)
$20.00M
Revenue Growth
+700.00%
P/S Ratio
67.41
Revenue / Employee
$141,844
Employees
141
Market Cap
1.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 167.50M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
MAZE News
- 2 days ago - Maze Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 7 days ago - Maze Therapeutics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 8 days ago - Maze Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 15 days ago - Maze Therapeutics to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Maze Therapeutics Announces Appointments to Its Board of Directors - GlobeNewsWire
- 5 weeks ago - Maze Therapeutics reports Q2 EPS (76c), consensus (70c) - TheFly
- 5 weeks ago - Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 5 weeks ago - Maze Therapeutics Earnings release: Q2 2026 - Filings